JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 14, 2005; DOI: 10.1124/jpet.105.090498


0022-3565/05/3152-601-608$20.00
JPET 315:601-608, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.090498v1
315/2/601    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holt, J. D. S.
Right arrow Articles by Chang, K.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holt, J. D. S.
Right arrow Articles by Chang, K.-J.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

DPI-221 [4-(({alpha}-S)-{alpha}-((2S,5R)-2,5-Dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: A Novel Nonpeptide {delta} Receptor Agonist Producing Increased Micturition Interval in Normal Rats

Jonathon D. S. Holt, Michael J. Watson, Jane P. Chang, Scott J. O'Neill, Ke Wei, William Pendergast, Peter J. Gengo, and Kwen-Jen Chang

Enhance Biotech, Inc., Durham, North Carolina

There is a wealth of information from animal models and clinical opioid-analgesic use that indicates a significant role for opioid receptors in the modulation of bladder activity. The novel benzhydrylpiperazine compound DPI-221 [4-(({alpha}-S)-{alpha}-((2S,5R)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide] was characterized as having {delta} receptor selectivity using radioligand binding (Ki = 2.0 ± 0.7 nM, {delta} receptor; 1800 ± 360 nM, µ receptor; and 2300 ± 680 nM, {kappa} receptor), and agonist activity was demonstrated in the mouse isolated vas deferens where DPI-221 inhibited electrically induced contractions with an IC50 value of 88 ± 7.5 nM. In the guinea pig isolated ileum, DPI-221 had no effect on electrically induced contractions at concentrations as high as 1 µM. Sterile saline was infused (7 ml/h) into the bladder of Sprague-Dawley rats, via a transmural catheter; DPI-221 (1.0 to 20 mg/kg p.o.) significantly increased the interval between micturition events, whereas peak void pressure was not significantly decreased by any dose of DPI-221. The micturition effects of 10 mg/kg p.o. DPI-221 were blocked by naltrindole, indicating a {delta} receptor mechanism of action. In isolated rat bladder strips, DPI-221 was ineffective at relaxing detrusor muscle precontracted with carbachol. The most crucial safety aspect of {delta} agonist administration is the incidence of seizure-like convulsions in rodents. DPI-221 produced no convulsions at doses up to 100 mg/kg p.o. in mice, although rapid bolus i.v. injection of 5 mg/kg produced convulsions in 3% of mice tested. These findings indicate a good safety profile for DPI-221 administered orally, with potent efficacy in modifying bladder activity.


Received June 17, 2005; accepted July 12, 2005.

Address correspondence to: Jonathon Holt, Enhance Biotech, Inc., 631 United Drive, Suite 200, Durham, NC 27713. E-mail: jholt{at}enhancebiotech.com




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
E. S. R. Lashinger, M. S. Steiginga, J. P. Hieble, L. A. Leon, S. D. Gardner, R. Nagilla, E. A. Davenport, B. E. Hoffman, N. J. Laping, and X. Su
AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F803 - F810.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.